We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Targa Resources
TRGP
$56.4B
| $4.08M | 0.02% |
23,465
+5,042
| +27% | +$847K |
|
602
Bausch + Lomb
BLCO
$5.96B
| $4.07M | 0.02% |
312,823
| – | – |
|
603
Tarsus Pharmaceuticals
TARS
$2.67B
| $4.06M | 0.02% |
100,149
| – | – |
|
604
Entergy
ETR
$50.8B
| $4.01M | 0.02% |
48,278
+12,050
| +33% | +$995K |
|
605
Nasdaq
NDAQ
$52.3B
| $4M | 0.02% |
44,716
+9,754
| +28% | +$779K |
|
606
GFL Environmental
GFL
$15.2B
| $3.98M | 0.02% |
+78,910
| New | +$3.87M |
|
607
FIGS
FIGS
$1.81B
| $3.96M | 0.02% |
702,823
+5,871
| +0.8% | +$27.1K |
|
608
Ingevity
NGVT
$2.6B
| $3.96M | 0.02% |
+91,843
| New | +$3.54M |
|
609
Consolidated Edison
ED
$40B
| $3.91M | 0.02% |
38,972
+9,701
| +33% | +$1.03M |
|
610
Wabtec
WAB
$50.5B
| $3.88M | 0.02% |
18,510
+4,076
| +28% | +$784K |
|
611
Summit Therapeutics
SMMT
$11B
| $3.87M | 0.02% |
+182,012
| New | +$4.15M |
|
612
Huntsman Corp
HUN
$1.83B
| $3.76M | 0.02% |
+360,923
| New | +$4.4M |
|
613
Aligos Therapeutics
ALGS
$29.4M
| $3.74M | 0.02% |
518,300
+202,917
| +64% | +$1.21M |
|
614
VICI Properties
VICI
$29.3B
| $3.73M | 0.02% |
114,303
+25,241
| +28% | +$803K |
|
615
Waste Management
WM
$90B
| $3.73M | 0.02% |
16,282
-1,421
| -8% | -$330K |
|
616
CoStar Group
CSGP
$12.1B
| $3.67M | 0.02% |
45,635
+10,031
| +28% | +$781K |
|
617
Structure Therapeutics
GPCR
$3.53B
| $3.66M | 0.02% |
176,453
+1,029
| +0.6% | +$22.6K |
|
618
Akebia Therapeutics
AKBA
$354M
| $3.64M | 0.02% |
1,001,360
-1,484,218
| -60% | -$4.08M |
|
619
Agilent Technologies
A
$39.3B
| $3.64M | 0.02% |
30,839
-491,234
| -94% | -$54.4M |
|
620
WEC Energy
WEC
$35.6B
| $3.6M | 0.02% |
34,520
+7,681
| +29% | +$817K |
|
621
Relay Therapeutics
RLAY
$4.26B
| $3.52M | 0.02% |
1,018,115
-500,446
| -33% | -$1.49M |
|
622
Tenable Holdings
TENB
$3.96B
| $3.48M | 0.02% |
102,964
-87,251
| -46% | -$2.83M |
|
623
Jazz Pharmaceuticals
JAZZ
$16.4B
| $3.47M | 0.02% |
32,684
-69,366
| -68% | -$7.54M |
|
624
Knight Transportation
KNX
$11.7B
| $3.47M | 0.02% |
+78,380
| New | +$3.33M |
|
625
Ryman Hospitality Properties
RHP
$8.09B
| $3.45M | 0.02% |
+35,000
| New | +$3.27M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.